| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EIGER BIOPHARMACEUTICALS INC | 3,333 | 45,000 | 0.01% | ||
| 2 | QUORUM HEALTH CORP | 12,500 | 78,000 | 0.01% | ||
| 3 | MYRIAD GENETICS INC | 14,000 | 288,000 | 0.05% | ||
| 4 | SURGERY PARTNERS INCORPORATED | 15,000 | 304,000 | 0.05% | ||
| 5 | WebMD Health Corp | 7,400 | 368,000 | 0.07% | ||
| 6 | PENUMBRA INC COM | 5,000 | 380,000 | 0.07% | ||
| 7 | RESMED INC | 8,000 | 518,000 | 0.09% | ||
| 8 | Esperion Therapeutics Inc | 40,000 | 554,000 | 0.10% | ||
| 9 | INSULET CORPORATION | 15,000 | 614,000 | 0.11% | ||
| 10 | CELLDEX THERAPEUTICS INC NEW | 160,000 | 646,000 | 0.12% | ||
| 11 | DAVITA INC | 10,000 | 661,000 | 0.12% | ||
| 12 | Theravance Biopharma Inc | 18,428 | 668,000 | 0.12% | ||
| 13 | NOVAVAX INC COM | 325,000 | 676,000 | 0.12% | ||
| 14 | VARIAN MED SYS I | 7,000 | 697,000 | 0.13% | ||
| 15 | UNITED THERAPEUTICS | 6,300 | 744,000 | 0.13% | ||
| 16 | EXELIXIS INC | 60,000 | 767,000 | 0.14% | ||
| 17 | KITE PHARMA INCORPORATED | 14,000 | 782,000 | 0.14% | ||
| 18 | AAC HLDGS INC COM | 45,000 | 783,000 | 0.14% | ||
| 19 | NEVRO CORP | 7,500 | 783,000 | 0.14% | ||
| 20 | GW PHARMACEUTICALS PLC | 6,000 | 796,000 | 0.14% | ||
| 21 | TEAM HEALTH HOLDINGS INCORPORATED | 25,000 | 814,000 | 0.15% | ||
| 22 | PORTOLA PHARMACEUTICALS INC | 36,000 | 818,000 | 0.15% | ||
| 23 | QUOTIENT LTD | 110,000 | 860,000 | 0.16% | ||
| 24 | CVS HEALTH CORP | 9,700 | 863,000 | 0.16% | ||
| 25 | ENVISION HEALTHCARE HLDGS INC | 39,000 | 869,000 | 0.16% | ||
| 26 | ABBVIE INC | 15,000 | 946,000 | 0.17% | ||
| 27 | MOLINA HEALTHCARE INC | 16,500 | 962,000 | 0.17% | ||
| 28 | ALDER BIOPHARMACEUTICALS INC | 33,000 | 1,081,000 | 0.20% | ||
| 29 | TELEFLEX INC | 6,500 | 1,092,000 | 0.20% | ||
| 30 | LABORATORY CORP AMER HLDGS | 8,000 | 1,100,000 | 0.20% | ||
| 31 | JUNO THERAPEUTICS INCORPORATED | 37,000 | 1,110,000 | 0.20% | ||
| 32 | DIREXION DAILY S&P BIOTECH BULL 3X SHARES | 25,175 | 1,228,000 | 0.22% | ||
| 33 | BRISTOL MYERS SQUIBB CO | 23,000 | 1,240,000 | 0.22% | ||
| 34 | ALERE INC | 30,000 | 1,297,000 | 0.23% | ||
| 35 | INSYS THERAPEUTICS INC NEW COM NEW | 115,000 | 1,356,000 | 0.24% | ||
| 36 | ACADIA PHARMACEUTICALS INC COM | 45,000 | 1,431,000 | 0.26% | ||
| 37 | INOVIO PHARMACEUTICALS INC | 155,000 | 1,445,000 | 0.26% | ||
| 38 | HEALTHCARE SVCS GROUP INC COM | 38,100 | 1,508,000 | 0.27% | ||
| 39 | CLOVIS ONCOLOGY INC | 43,000 | 1,550,000 | 0.28% | ||
| 40 | ALNYLAM PHARMACEUTICALS INC | 24,000 | 1,627,000 | 0.29% | ||
| 41 | PFIZER INC | 50,000 | 1,694,000 | 0.31% | ||
| 42 | Wright Medical Group NV | 70,309 | 1,725,000 | 0.31% | ||
| 43 | AETNA INC NEW | 16,400 | 1,893,000 | 0.34% | ||
| 44 | HUMANA | 10,800 | 1,910,000 | 0.35% | ||
| 45 | ACHILLION PHARMACEUTICALS INC COM | 240,000 | 1,944,000 | 0.35% | ||
| 46 | BLUEBIRD BIO INCORPORATED | 29,000 | 1,966,000 | 0.36% | ||
| 47 | GLOBUS MED INC | 87,700 | 1,979,000 | 0.36% | ||
| 48 | EAGLE PHARMACEUTICALS INC COM | 29,000 | 2,030,000 | 0.37% | ||
| 49 | HORIZON PHARMA PLC | 117,000 | 2,121,000 | 0.38% | ||
| 50 | PROSHARES TR | 45,500 | 2,205,000 | 0.40% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-021740, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
